Aurobindo Pharma Ltd, on 27 December, announced that its wholly-owned arm Eugia Pharma Specialities Ltd had received final approval from the USFDA (US Food and...
Aurobindo Pharma shares hit a 52-week high of Rs 1,081.95 on 20 December after the company informed that its wholly owned subsidiary, APL Healthcare Limited,...
Shares of Aurobindo Pharma were trading in the green and 2% higher on 30 November after the companyβs wholly-owned subsidiary received final approval from the...
Aurobindo Pharma’s shares were trading in the red after the company’s subsidiary, APL Healthcare Limited, on 20 September received a ‘Form 483’ with one observation...
Aurobindo Pharma on 17 August announced that it will launch a tablet to treat HIV in low-to-middle-income countries. Headquartered in Hyderabad, Aurobindo Pharma manufactures a...
Eugia Pharma Specialities, a wholly-owned subsidiary of Aurobindo Pharma, on 16 August received approval from the USFDA (United States Food and Drug Administration to manufacture...